Jailendra Singh

Q: What is Jailendra Singh's success rate?

Jailendra Singh currently has a success rate of 94.95396966868965.

Q: What is the average return of Jailendra Singh's calls?

Their stock ratings have generated an average return of 13.946331806927427.

Truist Securities | Healthcare

Jailendra Singh is an analyst from Truist Securities specializing in the Healthcare sector. Ranked #1267 out of 4706 analysts, they have issued 38 stock ratings with a success rate of 94.95% and an average return of 13.95%.

Jailendra Singh has a well-established track record, with 38 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 94.95% and an average return of 13.95%, underscoring their expertise and ability to identify winning opportunities for investors.

#1267

Out of 4706

Total Ratings

+94.95%

Success Rate

+13.95%

Average Return

Recent Ratings Analysis

EVH

Hold

Jun 30, 2026

Target

$7.00

Current

$5.42

Performance

0.00%

Jailendra Singh rated EVH as Hold on Jun 30, 2026, setting a price target of 7. The Hold stance appears justified, as shares hovered around 5.42 with a 0.00% move.

ICLR

Buy

Jun 30, 2026

Target

$207.00

Current

$173.71

Performance

0.00%

On Jun 30, 2026, ICLR was given a Buy rating by Jailendra Singh, with a target price of 207. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

PGNY

Buy

Jun 22, 2026

Target

$33.00

Current

$28.83

Performance

9.70%

PGNY received a Buy rating from Jailendra Singh on Jun 22, 2026, aiming for 33. Momentum has favored the Buy call, with shares climbing from 28.83 to 28.83, rewarding those who trusted the recommendation.

HNGE

Buy

Jun 11, 2026

Target

$85.00

Current

$83.00

Performance

28.19%

On Jun 11, 2026, Jailendra Singh published a Buy outlook on HNGE, with a target of 85. Shares gained 28.19%, underscoring the accuracy of the bullish outlook toward 85.

PHR

Hold

May 29, 2026

Target

$12.00

Current

$10.29

Performance

4.36%

Jailendra Singh on May 29, 2026 assigned PHR a Hold rating, with a price target of 12. The Hold stance reflected consolidation, as shares held near 10.29.

HIMS

Hold

May 22, 2026

Target

$23.00

Current

$34.67

Performance

45.98%

On May 22, 2026, Jailendra Singh reaffirmed HIMS with a Hold rating, targeting 23. Market strength beyond 34.67 went further than the conservative outlook suggested.

DOCS

Hold

May 14, 2026

Target

$19.00

Current

$20.74

Performance

15.16%

DOCS was rated Hold by Jailendra Singh on May 14, 2026, with a price objective of 19. Despite caution, upside momentum rewarded risk-takers with gains to 20.74.

ASTH

Buy

May 14, 2026

Target

$47.00

Current

$46.41

Performance

18.51%

On May 14, 2026, Jailendra Singh initiated coverage on ASTH with a Buy rating and target of 47. The stock’s climb of 18.51% since the call highlights the foresight in the rating.

VEEV

Buy

Mar 05, 2026

Target

$275.00

Current

$177.47

Performance

—

Jailendra Singh issued a Buy recommendation for VEEV on Mar 05, 2026, price target set at 275. The target of 275 remains in play, though confirmation will depend on future moves.

PRVA

Buy

Mar 02, 2026

Target

$33.00

Current

$25.73

Performance

7.03%

On Mar 02, 2026, PRVA was evaluated by Jailendra Singh, who gave a Buy rating and target of 33. This case illustrates how a timely bullish rating can translate into tangible gains of 7.03%.

IQV

Buy

Feb 19, 2026

Target

$290.00

Current

$193.22

Performance

14.09%

Jailendra Singh rated IQV as Buy on Feb 19, 2026, setting a price target of 290. The call has proven timely, with shares rising 14.09% toward the price target of 290.

WAY

Buy

Feb 18, 2026

Target

$51.00

Current

$20.53

Performance

-19.21%

On Feb 18, 2026, WAY was given a Buy rating by Jailendra Singh, with a target price of 51. Despite the Buy call, shares fell from 20.53 to 20.53, challenging the optimistic stance.

MEDP

Hold

Feb 11, 2026

Target

$555.00

Current

$529.59

Performance

24.92%

MEDP received a Hold rating from Jailendra Singh on Feb 11, 2026, aiming for 555. Investors saw gains of 24.92% that the cautious stance didn’t fully capture.

MDLN

Buy

Jan 12, 2026

Target

$52.00

Current

$39.44

Performance

-7.68%

On Jan 12, 2026, Jailendra Singh published a Buy outlook on MDLN, with a target of 52. Market action contradicted the Buy thesis, as shares slipped to 39.44.

FTRE

Buy

Jan 08, 2026

Target

$22.00

Current

$17.40

Performance

-0.23%

Jailendra Singh on Jan 08, 2026 assigned FTRE a Buy rating, with a price target of 22. The recommendation remains pending validation as shares consolidate around 17.4.

GDRX

Hold

Apr 10, 2025

Target

$5.50

Current

$2.88

Performance

-33.33%

On Apr 10, 2025, Jailendra Singh reaffirmed GDRX with a Hold rating, targeting 5.5. The Hold stance reflected market caution that was later justified.

AMWL

Hold

Apr 10, 2025

Target

$7.50

Current

$9.12

Performance

25.79%

AMWL was rated Hold by Jailendra Singh on Apr 10, 2025, with a price objective of 7.5. Despite caution, upside momentum rewarded risk-takers with gains to 9.12.

ACCD

Buy

Oct 09, 2024

Target

$7.50

Current

$7.02

Performance

80.00%

On Oct 09, 2024, Jailendra Singh initiated coverage on ACCD with a Buy rating and target of 7.5. The stock’s climb of 80.00% since the call highlights the foresight in the rating.

TDOC

Hold

Aug 02, 2024

Target

$10.00

Current

$8.48

Performance

6.67%

Jailendra Singh issued a Hold recommendation for TDOC on Aug 02, 2024, price target set at 10. A neutral call gave way to stronger-than-expected performance, closing in on 10.

CNH

Buy

Jul 02, 2024

Target

$14.00

Current

$11.23

Performance

15.18%

On Jul 02, 2024, CNH was evaluated by Jailendra Singh, who gave a Buy rating and target of 14. This case illustrates how a timely bullish rating can translate into tangible gains of 15.18%.

AGL

Hold

Jan 05, 2024

Target

$10.00

Current

$107.18

Performance

-50.32%

Jailendra Singh rated AGL as Hold on Jan 05, 2024, setting a price target of 10. The cautious Hold call aligned with subsequent weakness, as shares slipped 50.32%.

Frequency Asked Questions

Who is Jailendra Singh?

Jailendra Singh is an analyst from Truist Securities specializing in the Healthcare sector.

What is Jailendra Singh's success rate?

Jailendra Singh currently has a success rate of +94.95%.

How many ratings has Jailendra Singh issued?

Jailendra Singh has issued 38 stock ratings so far.

What is the average return of Jailendra Singh's calls?

Their stock ratings have generated an average return of +13.95%.

What is Jailendra Singh's ranking?

Jailendra Singh is ranked #1267 out of 4706 analysts.

What types of ratings does Jailendra Singh give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Jailendra Singh?

You can follow Jailendra Singh by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Jailendra Singh?

Their latest rating was a Hold on EVH issued on 2026-06-30.